Indian pharma companies may benefit under Trump 2.0 2 min read Business Indian pharma companies may benefit under Trump 2.0 Daily News Express November 20, 2024 NEW DELHI: The Trump 2.0 agenda, with its likely focus on China plus 1 strategy for pharmaceutical...Read More
